Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-04-26

Clinical Trial Update: Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems

View source ↗

Summary

A completed study comparing long-term effects of HAART in youths with stronger immune systems versus youths with weaker immune systems.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HAART (Highly Active Antiretroviral Therapy)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Status: COMPLETED